As it may be show up on the Goog.. search engine pop up, as smooth-muscle tumor, Leiomyomas are commonly known as fibroids that many workmen in child bearing age discover several time sin their life during an ultrasound (sonography) examination or otherwise during some gynaecological complaints. The facts may not be the same and we may need a wisdom to understand this as a condition or look into it deeper to see if it is a real problem at the hands of your gynaecologist to help you contain the condition!
An Up To date Excerpt for Abnormal uterine bleeding (AUB) (a term which refers to menstrual bleeding of abnormal quantity, duration, or schedule) is a common gynecologic complaint, accounting for one-third of outpatient visits to gynaecologists.
The most common etiologies in nonpregnant women are structural uterine pathology (condition and its study) (eg, fibroids, endometrial polyps, adenomyosis), an ovulation (menstrual cycle during which the ovaries do not release an oocyte or egg), disorders of homeostasis (Imbalance of Blood components- Refer module 1 we posted a while ago), or neoplasia (A growth is called neoplasia that is new but may not be abnormal).
Fibroids are often described according to their location in the uterus, although many fibroids have more than one location designation, such as Intramural myomas (These leiomyomas develop from within the uterine wall). Submucosal myomas (These leiomyomas derive from myometrial cells just below the endometrium). Subserosal myomas (These leiomyomas originate from the myometrium at the serosal surface of the uterus).Cervical myomas (These leiomyomas are located in the cervix, rather than the uterine corpus).
Risk factors could be :
- RISK FACTORS
- Menstrual history and parity
- Hormonal contraception
- Ovulation induction agents
- Diet, caffeine, and alcohol use
Good news for some who may find the AUB as scary condition may note that a very respected site for medical references states, ” Heavy and/or prolonged menses is the typical bleeding pattern with myomas and the most common fibroid symptom. Intermenstrual bleeding and postmenopausal bleeding are NOT characteristic of myomas and should be investigated to exclude endometrial pathology. Heavy uterine bleeding may be responsible for associated problems, such as iron deficiency anemia, social embarrassment, and lost productivity in the work force.
Some CTA (call to action) points are :
- Uterine leiomyomas (fibroids or myomas) are the most common pelvic tumor in women (cumulative incidence by age 50 of >80 percent for black women and almost 70 percent for white women). The incidence of leiomyomas parallels the life cycle changes of the reproductive hormones estrogen and progesterone.
- Leiomyomas are benign monoclonal tumors arising from the smooth muscle cells of the myometrium. Fibroids are often described according to their location in the uterus (submucosal, intramural, subserosal, cervical).
- Relief of symptoms related to fibroids usually occurs at the time of menopause, when menstrual cyclicity stops and steroid hormone levels wane. Most, but not all, women have shrinkage of leiomyomas at menopause. Use of postmenopausal hormone therapy may cause some women with leiomyomas to continue to have symptoms after menopause. Hormone therapy may be associated with an increase in size of existing myomas, but not with the development of new myomas.
There are many treatments for fibroids, and it can be hard to decide which one is right. You should choose a treatment based upon your fibroid-related symptoms.
●If you are bothered by heavy menstrual bleeding, you can first try the medical treatments. Hormonal birth control, nonsteroidal antiinflammatory drugs (NSAIDs), or antifibrinolytic medicines work better than other medical treatments.
Some women who no longer want future pregnancies can also be treated with endometrial ablation to reduce bleeding.
If medical treatment or endometrial ablation are not good options for you, or you also have symptoms related to the size of the fibroids, you can consider uterine fibroid embolization, myomectomy, hysterectomy or focused ultrasound surgery.